tiprankstipranks

David Young Insider Profile

4 Followers
David Young, Pres. Research & Development, Director at Processa Pharmaceuticals, holds 24.41K shares in Processa Pharmaceuticals (Ticker: PCSA), holds 117.74K shares in Questcor (Ticker: QCOR). Most recently, David Young Bought ― shares of Processa Pharmaceuticals on Jul 01, 2026 for an estimated value of $4.88K.
tipranks
David Young

David Young
Processa Pharmaceuticals (PCSA)
Pres. Research & Development, Director

Ranked #104,193 out of 108,328 Corporate Insiders

Profitable Transactions

14%
2 out of 14 Profitable Transactions

Average Return

-44.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$52K
100.00%
A breakdown of David Young's holdings

Insider Roles

Processa Pharmaceuticals
(PCSA)
Pres. Research & Development, Director
Roles that David Young holds in companies

Most Profitable Insider Trade

Stock:
Processa Pharmaceuticals
(PCSA)
Rating:Informative Buy
Date:Jul 01, 2026 - Today
Return:+9.60%
The most profitable trade made by David Young

David Young's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Processa Pharmaceuticals
Jul 01, 2026
Pres. Research & Development, Director
Informative Buy
4.88K
$52.49K
QCOR
Questcor
Jun 26, 2014
Uninformative Sell
551.76K
List of latest transactions for each holding click on a transaction to see David Young's performance on stock

David Young insider profile FAQ

What is the percentage of profitable transactions made by David Young?
The percentage of profitable transactions made by David Young is 14%.
    What is the average return per transaction made by David Young?
    The average return per transaction made by David Young is -44.30%.
      What stocks does David Young hold?
      David Young holds: PCSA, QCOR stocks.
        What was David Young’s latest transaction?
        David Young latest transaction was an Informative Buy of $4.88K.
          What was David Young's most profitable transaction?
          David Young’s most profitable transaction was an Informative Buy of PCSA stock on July 1, 2026. The return on the trade was 9.60%.
            What is David Young's role in Processa Pharmaceuticals?
            David Young's role in Processa Pharmaceuticals is Pres. Research & Development, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.